Complimentary Elsevier Webinar, Wednesday Morning, Feb.15, 2012
Topic: “Outlook for the Biomedical Industry in 2012: What’s Affecting Innovation?”
Speakers: David L. Gollaher, Ph.D., President and Chief Executive Officer, CHI-California Healthcare Institute; Gail Maderis, President and CEO of BayBio; and David Yeary, Vice President, Merrill Datasite - Life Sciences
Moderator: Audrey Erbes, Ph.D., Industry Blogger, Adjunct Instructor at UC Berkeley Extension, and Biopharmaceutical Business Development Consultant
Date and Time: Wednesday, Feb. 15, 2012, 10:00-11:00 AM PT/1:00-2:00 PM ET
Cost: Free, complimentary webinar
Register: http://www.elsevierbi.com/mkt/Webinars/SP/AC021512Reg
See further details at http://view.elsevierbi.net/?j=fe551578706200747216&m=fef312777d6007&ls=f...
Topic Description
Join CHI-California Healthcare Institute and MERRILL DATASITE®, for a free, complimentary webinar where experts will review highlights from the January 9th-12th J.P. Morgan Healthcare Conference, in addition to the recently released 2012 Biomedical Industry Report, published by CHI, BayBio and PwC. We will look at forces shaping business decisions at private and public biomedical companies, both small and large, as the annual report’s CEO Survey is revealed.
Complete this form to register. You will immediately receive an email confirming your registration.
Speaker and Moderator Bios
David L. Gollaher, Ph.D., President and Chief Executive Officer, CHI-California Healthcare Institute co-founded CHI in 1993. Previously, he was a senior executive at Scripps Clinic and Research Foundation. Earlier in his career, he served on the faculties of Harvard University, University of California, San Diego, the Graduate School of Public Health at SDSU, and the Overseas School of Rome. He is an award-winning historian of science and medicine, and has written three books and numerous articles in the fields of health policy, the economics of biomedical research and development, bioethics and the history of medicine. Gollaher completed his undergraduate studies at the University of California and earned his master's and doctorate degrees from Harvard University.
Gail Maderis is President & CEO of BayBio, the industry organization representing and supporting Northern California’s life science community. As a former biotech CEO, Ms. Maderis brings deep experience and commitment to supporting the industry through enterprise development, peer-to-peer experience sharing, advocacy and support of education and workforce development. From 2003 to 2009, Ms. Maderis served as President and CEO of Five Prime Therapeutics, Inc., a privately held protein discovery and development company. At FivePrime, she successfully funded the company’s rapid growth through substantial private equity financings and corporate partnerships and took the company’s first novel cancer therapeutic from discovery into clinical trials. Prior to FivePrime, Ms. Maderis held senior executive positions at Genzyme Corporation, including founder and president of Genzyme Molecular Oncology (GZMO). Ms. Maderis practiced management and strategy consulting with Bain & Co. She serves on the boards of BayBio, the Mayor’s Biotech Advisory Council of San Francisco and the HBS Healthcare Initiative. She received a BS in business from the UC Berkeley and an MBA from Harvard Business School.
David Yeary is the Vice President of Sales-Life Sciences for Merrill's DataSite. Most recently, Yeary worked at Morgan Lewis as Director, Business and Practice Development where he assisted and led business development opportunities in Life Sciences, Technology, Clean Tech and Digital Media and Entertainment. He also worked with private equity, venture capital and investment banks to bridge between client and investor. Yeary gained his experience at Synarc, Celera, IMS, Agouron/Pfizer and Roche/Syntex in various business development, sales and marketing roles. He has and continues to work with numerous startups as an advisor for business development, commercialization and marketing and communication functions. Periodically he can be heard on the radio or speaking at Stanford discussing the challenges and opportunities for the new entrepreneur. He holds a BS and MBA in business from California State University, Fresno.
Audrey Erbes, Ph.D., is a global life-science business development and marketing consultant working with emerging biopharma companies, industry educator and blogger, and organization leader who originated several applied, intensive bioscience business development and marketing courses for working professionals in 2002. She blogs weekly via www.AudreysNetwork.com, teaches at UC Berkeley Extension and is VP, Bay Area Bio2Device Group. She has 25 years of managerial experience in the corporate biopharmaceutical industry including VP and Cofounder of Kowa Research Institute, a biopharma subsidiary of Kowa Company Ltd., Japan from 1997-2001. Previously, she held both U.S. and international management positions at Syntex Corporation (acquired by Roche) in product management, strategic marketing, and business development. She holds an M.A. and Ph.D. in political science from the University of Florida and B.A. from Valparaiso University.
